• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study.

作者信息

Martinho António C-V, Marques Inês P, Messias Ana L, Santos Torcato, Madeira Maria H, Sousa David C, Lobo Conceição, Cunha-Vaz José

机构信息

AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal.

Dentistry Department, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

出版信息

Diabetes Care. 2021 Jan;44(1):e12-e14. doi: 10.2337/dc20-1125. Epub 2020 Nov 6.

DOI:10.2337/dc20-1125
PMID:33158947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7783945/
Abstract
摘要

相似文献

1
Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study.2型糖尿病患者发生黄斑水肿和增殖性视网膜病变的眼部及全身风险标志物：一项5年纵向研究
Diabetes Care. 2021 Jan;44(1):e12-e14. doi: 10.2337/dc20-1125. Epub 2020 Nov 6.
2
Epidemiology of Ocular Functions and Diseases in Persons With Diabetes糖尿病患者眼部功能与疾病的流行病学
3
The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.在未检测到临床糖尿病性黄斑水肿的眼中，黄斑厚度与临床分级的糖尿病视网膜病变严重程度之间的关系。
Ophthalmology. 2008 Mar;115(3):533-539.e2. doi: 10.1016/j.ophtha.2007.06.042. Epub 2007 Dec 11.
4
[Combination therapy in patients with concomitant macular edema and proliferative diabetic retinopathy].[黄斑水肿合并增殖性糖尿病视网膜病变患者的联合治疗]
Vestn Oftalmol. 2019;135(6):67-72. doi: 10.17116/oftalma201913506167.
5
Retinal microaneurysm counts and 10-year progression of diabetic retinopathy.视网膜微动脉瘤计数与糖尿病视网膜病变的10年进展
Arch Ophthalmol. 1995 Nov;113(11):1386-91. doi: 10.1001/archopht.1995.01100110046024.
6
Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy.2型糖尿病患者中与黄斑水肿和增殖性视网膜病变风险不同相关的视网膜病变表型
J Clin Med. 2020 May 12;9(5):1433. doi: 10.3390/jcm9051433.
7
Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone.与单纯血糖控制不佳相比，糖尿病控制指标综合不佳与糖尿病视网膜病变和黄斑水肿的风险更高相关。
PLoS One. 2017 Jun 29;12(6):e0180252. doi: 10.1371/journal.pone.0180252. eCollection 2017.
8
Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy.联合改良格栅与全视网膜光凝治疗弥漫性糖尿病性黄斑水肿和增殖性糖尿病视网膜病变。
Ophthalmic Surg Lasers. 2000 Jul-Aug;31(4):292-300.
9
Long-term visual acuity results of treated and untreated radiation retinopathy (an AOS thesis).治疗与未治疗的放射性视网膜病变的长期视力结果（一篇美国眼科学会论文）
Trans Am Ophthalmol Soc. 2008;106:325-35.
10
Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes.内皮型一氧化氮合酶基因与2型糖尿病性黄斑水肿相关。
Diabetes Care. 2004 Sep;27(9):2184-90. doi: 10.2337/diacare.27.9.2184.

引用本文的文献

1
Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema.血管造影生物标志物是预测糖尿病性黄斑水肿患者接受玻璃体内注射阿柏西普治疗反应的重要指标。
Sci Rep. 2023 May 19;13(1):8128. doi: 10.1038/s41598-023-35286-2.
2
Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study.非增殖性糖尿病视网膜病变进展的不同风险特征：一项为期两年的研究。
Ophthalmol Ther. 2023 Feb;12(1):485-500. doi: 10.1007/s40123-022-00623-7. Epub 2022 Dec 10.
3
Perspectives of diabetic retinopathy-challenges and opportunities.糖尿病视网膜病变的研究进展：挑战与机遇
Eye (Lond). 2023 Aug;37(11):2183-2191. doi: 10.1038/s41433-022-02335-5. Epub 2022 Dec 9.
4
Characterisation of progression of macular oedema in the initial stages of diabetic retinopathy: a 3-year longitudinal study.糖尿病视网膜病变初始阶段黄斑水肿进展的特征：一项为期3年的纵向研究。
Eye (Lond). 2023 Feb;37(2):313-319. doi: 10.1038/s41433-022-01937-3. Epub 2022 Jan 22.
5
Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy.糖尿病视网膜病变风险表型的一年进展特征
Ophthalmol Ther. 2022 Feb;11(1):333-345. doi: 10.1007/s40123-021-00437-z. Epub 2021 Dec 5.
6
Characterization of Risk Profiles for Diabetic Retinopathy Progression.糖尿病视网膜病变进展风险特征的描述
J Pers Med. 2021 Aug 23;11(8):826. doi: 10.3390/jpm11080826.
7
Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study.轻度非增殖性糖尿病视网膜病变中微动脉瘤的周转率与视力威胁性并发症的进展和发生相关：一项5年纵向研究
J Clin Med. 2021 May 15;10(10):2142. doi: 10.3390/jcm10102142.

本文引用的文献

1
Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy.2型糖尿病患者中与黄斑水肿和增殖性视网膜病变风险不同相关的视网膜病变表型
J Clin Med. 2020 May 12;9(5):1433. doi: 10.3390/jcm9051433.
2
The Role of Systemic Risk Factors in Diabetic Retinopathy.全身风险因素在糖尿病视网膜病变中的作用。
Curr Ophthalmol Rep. 2016;4(2):84-89. doi: 10.1007/s40135-016-0098-8. Epub 2016 Mar 25.